Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. Its product pipeline includes Cirmtuzumab, TK216, and ROR1 CAR-T.GTx Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of small molecules for treatment of cancer, including treatments for breast and prostate cancer and other medical conditions.